BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28441008)

  • 1. Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer.
    Cheng Z; Choi N; Wang R; Lee S; Moon KC; Yoon SY; Chen L; Choo J
    ACS Nano; 2017 May; 11(5):4926-4933. PubMed ID: 28441008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous immunoassays of dual prostate cancer markers using a SERS-based microdroplet channel.
    Gao R; Cheng Z; Wang X; Yu L; Guo Z; Zhao G; Choo J
    Biosens Bioelectron; 2018 Nov; 119():126-133. PubMed ID: 30121424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SERS-Temperature Dual-Mode T-type Lateral Flow Strip for Accurate Detection of Free and Total Prostate-Specific Antigens in Blood.
    Fang C; Li J; Lin B; Wang Y; Yao Y; Chen L; Zeng Y; Li L; Guo L
    Anal Chem; 2024 Jan; 96(2):721-729. PubMed ID: 38176009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wash-free magnetic immunoassay of the PSA cancer marker using SERS and droplet microfluidics.
    Gao R; Cheng Z; deMello AJ; Choo J
    Lab Chip; 2016 Mar; 16(6):1022-9. PubMed ID: 26879372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers.
    Zhou L; Liu Y; Wang F; Jia Z; Zhou J; Jiang T; Petti L; Chen Y; Xiong Q; Wang X
    Talanta; 2018 Oct; 188():238-244. PubMed ID: 30029370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SERS-Based Pump-Free Microfluidic Chip for Highly Sensitive Immunoassay of Prostate-Specific Antigen Biomarkers.
    Gao R; Lv Z; Mao Y; Yu L; Bi X; Xu S; Cui J; Wu Y
    ACS Sens; 2019 Apr; 4(4):938-943. PubMed ID: 30864786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SERS-based biosensor for detection of f-PSA%: Implications for the diagnosis of prostate cancer.
    Zhao J; Ma H; Liu Y; Xu B; Song L; Han X; Liu R; He C; Cheng Z; Zhao B
    Talanta; 2023 Aug; 261():124654. PubMed ID: 37196403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review on the simultaneous determination of total prostate-specific antigen and free prostate-specific antigen.
    van Iersel MP; Witjes WP; Thomas CM; Segers MF; Oosterhof GO; Debruyne FM
    Prostate Suppl; 1996; 7():48-57. PubMed ID: 8950364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free and complexed prostate-specific antigen (PSA) in the early detection of prostate cancer.
    Tello FL; Prats CH; González MD
    Clin Chem Lab Med; 2001 Feb; 39(2):116-20. PubMed ID: 11341744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-color magnetic-quantum dot nanobeads as versatile fluorescent probes in test strip for simultaneous point-of-care detection of free and complexed prostate-specific antigen.
    Rong Z; Bai Z; Li J; Tang H; Shen T; Wang Q; Wang C; Xiao R; Wang S
    Biosens Bioelectron; 2019 Dec; 145():111719. PubMed ID: 31563066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum.
    Fernández-Sánchez C; McNeil CJ; Rawson K; Nilsson O; Leung HY; Gnanapragasam V
    J Immunol Methods; 2005 Dec; 307(1-2):1-12. PubMed ID: 16277989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The simultaneous detection of free and total prostate antigen in serum samples with high sensitivity and specificity by using the dual-channel surface plasmon resonance.
    Jiang Z; Qin Y; Peng Z; Chen S; Chen S; Deng C; Xiang J
    Biosens Bioelectron; 2014 Dec; 62():268-73. PubMed ID: 25016334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-enhanced Raman scattering (SERS) spectroscopy for prostate cancer diagnosis: A review.
    Haroon M; Tahir M; Nawaz H; Majeed MI; Al-Saadi AA
    Photodiagnosis Photodyn Ther; 2022 Mar; 37():102690. PubMed ID: 34921990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining SERS analysis of serum with PSA levels for improving the detection of prostate cancer.
    Stefancu A; Moisoiu V; Couti R; Andras I; Rahota R; Crisan D; Pavel IE; Socaciu C; Leopold N; Crisan N
    Nanomedicine (Lond); 2018 Oct; 13(19):2455-2467. PubMed ID: 30284481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.
    Ishikawa T; Yoneyama T; Tobisawa Y; Hatakeyama S; Kurosawa T; Nakamura K; Narita S; Mitsuzuka K; Duivenvoorden W; Pinthus JH; Hashimoto Y; Koie T; Habuchi T; Arai Y; Ohyama C
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual monoclonal antibody immunoassay for free prostate-specific antigen.
    Wang TJ; Hill TM; Sokoloff RL; Frankenne F; Rittenhouse HG; Wolfert RL
    Prostate; 1996 Jan; 28(1):10-6. PubMed ID: 8545276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertical flow assays based on core-shell SERS nanotags for multiplex prostate cancer biomarker detection.
    Chen R; Liu B; Ni H; Chang N; Luan C; Ge Q; Dong J; Zhao X
    Analyst; 2019 Jul; 144(13):4051-4059. PubMed ID: 31157328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity immunoassay with surface plasmon field-enhanced fluorescence spectroscopy using a plastic sensor chip: application to quantitative analysis of total prostate-specific antigen and GalNAcβ1-4GlcNAc-linked prostate-specific antigen for prostate cancer diagnosis.
    Kaya T; Kaneko T; Kojima S; Nakamura Y; Ide Y; Ishida K; Suda Y; Yamashita K
    Anal Chem; 2015 Feb; 87(3):1797-803. PubMed ID: 25546230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Femtomolar detection of prostate-specific antigen: an immunoassay based on surface-enhanced Raman scattering and immunogold labels.
    Grubisha DS; Lipert RJ; Park HY; Driskell J; Porter MD
    Anal Chem; 2003 Nov; 75(21):5936-43. PubMed ID: 14588035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer.
    Van Cangh PJ; De Nayer P; Sauvage P; Tombal B; Elsen M; Lorge F; Opsomer R; Wese FX
    Prostate Suppl; 1996; 7():30-4. PubMed ID: 8950361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.